Point72 Asset Management, L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,263,800
-92.8%
110,000
-86.3%
0.01%
-94.4%
Q3 2022$31,391,000
-22.8%
801,600
-36.3%
0.12%
-27.3%
Q2 2022$40,675,000
+178.7%
1,259,300
+185.6%
0.17%
+196.6%
Q1 2022$14,597,000
+1.8%
441,000
+30.9%
0.06%
+1.8%
Q4 2021$14,332,000
-57.3%
336,900
-55.5%
0.06%
-61.2%
Q3 2021$33,560,000
+158.9%
757,400
+231.9%
0.15%
+153.4%
Q2 2021$12,964,000
-48.1%
228,200
-31.6%
0.06%
-50.4%
Q1 2021$24,977,000
+35.2%
333,700
+10.4%
0.12%
+23.2%
Q3 2020$18,471,000
+260.8%
302,214
+145.4%
0.10%
+187.9%
Q2 2020$5,120,000
-79.2%
123,134
-52.0%
0.03%
-72.5%
Q4 2018$24,566,000
-0.6%
256,459
+46.5%
0.12%
+17.6%
Q3 2018$24,719,000
+12.8%
175,000
+25.0%
0.10%
+17.2%
Q2 2018$21,914,000
+32.6%
140,000
+36.5%
0.09%
+26.1%
Q1 2018$16,526,000
+77.6%
102,600
+81.6%
0.07%
+72.5%
Q4 2017$9,306,000
-61.2%
56,500
-85.3%
0.04%
-62.6%
Q3 2017$23,957,000
+140.7%
384,550
+207.6%
0.11%
+91.1%
Q2 2017$9,955,000
-64.6%
125,000
-68.4%
0.06%
-64.3%
Q1 2017$28,094,000
+753.1%
395,300
+512.9%
0.16%
+582.6%
Q4 2016$3,293,000
-57.1%
64,500
-61.3%
0.02%
-57.4%
Q3 2016$7,672,000
+51.8%
166,600
-0.7%
0.05%
+58.8%
Q2 2016$5,053,000167,7000.03%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders